Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

  • ID: 3746069
  • Clinical Trials
  • Region: Global
  • 220 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Celgene Corporation
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE
Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

Summary

Our clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H1, 2016" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriatic Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Celgene Corporation
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE
List of Tables

List of Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Psoriatic Arthritis Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Psoriatic Arthritis

Apr 25, 2016: AbGenomics International Announces Promising Final Results from their Phase II Open-Label Clinical Study of AbGn-168H / Neihulizumab in Psoriatic Arthritis, a T-cell Mediated Disease

Apr 05, 2016: Pfizer Announces Positive Top-Line Results From The First Phase 3 Trial Of Investigational Tofacitinib In Adults With Psoriatic Arthritis

Mar 16, 2016: Significantly higher persistence with SIMPONI (golimumab) in patients with rheumatic diseases compared with other subcutaneous TNF-alpha inhibitors, new study reveals

Mar 04, 2016: Oral OTEZLA (apremilast) Data from Open-Label Phase of ESTEEM and LIBERATE Trials to Be Presented at American Academy of Dermatology Congress

Mar 01, 2016: Lilly To Present Phase 3 Data At The American Academy Of Dermatology Annual Meeting For Ixekizumab In Psoriasis And Psoriatic Arthritis

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About us

Contact Us

Disclaimer

Source

List of Tables

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Region, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016-

Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016-

Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016-

Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Phase, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Psoriatic Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

List of Figures

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016-

Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016-

Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016-

Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016-

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Psoriatic Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Psoriatic Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

Methodology
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Pfizer Inc.
AbbVie Inc.
Johnson & Johnson
Novartis AG
Celgene Corporation
Merck & Co., Inc.
Amgen Inc.
UCB S.A.
C. H. Boehringer Sohn AG & Co. KG
Eli Lilly and Company
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll